Comparison of three different methods for radiolabelling human activated T lymphocytes

European Journal of Nuclear Medicine

Volumn 24, Issue 5, 1997, Pages 497-504

  Botti, Carlo ^a   Negri, Donatella R M ^a   Seregni, Ettore ^a   Ramakrishna, Venkatesh ^a   Arienti, Flavio ^a   Maffioli, Lorenzo ^a   Lombardo, Claudia ^a   Bogni, Anna ^a   Pascali, Claudio ^a   Crippa, Flavio ^a   Massaron, Simonetta ^a   Remonti, Federica ^a   Nerini Molteni, Silvia ^a   Canevari, Silvana ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adoptive immunotherapy; Bispecific monoclonal antibody; Fluorine 18 2 fluoro 2 deoxy D glucose; Indium 111 oxine; Lymphocyte radiolabelling; Ovarian cancer; Technetium hexamethylpropylene amine oxime

Indexed keywords

CD3 ANTIGEN; DRN 4908; FLUORODEOXYGLUCOSE F 18; GLYCOPROTEIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL COUNT; CELL DEATH; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; ISOTOPE LABELING; MOLECULAR RECOGNITION; OVARY CANCER; SCINTIGRAPHY; T LYMPHOCYTE ACTIVATION;

CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; INDIUM RADIOISOTOPES; ISOTOPE LABELING; LYMPHOCYTE ACTIVATION; ORGANOMETALLIC COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; OVARIAN NEOPLASMS; OXIMES; OXYQUINOLINE; T-LYMPHOCYTES; TECHNETIUM TC 99M EXAMETAZIME; TUMOR CELLS, CULTURED;

EID: 8244255923     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050081     Document Type: Article

References (43)

1. Rosenberg SA. The immunotherapy and gene therapy of cancer. J Clin Oncol 1992; 10: 180-199.
2. Chang AE, Shu S. Immunotherapy with sensitized lymphocytes. Cancer Invest 1992; 10: 357-369.
3. Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechofer R, Storer B, Sondel PM. The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2. Cancer 1990; 66: 2457-2464.
4. Freedman RS, Edwards CL, Kavanagh JJ, Kudelka AP, Katz RL, Carrasco CH, Atkinson EN, Scott W, Tomasovic B, Templin S. Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial. J Immunother 1994; 16: 198-210.
5. Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst 1994; 86: 1159-1166.
6. Perez P, Hoffman RW, Shaw S, Bluestone JA, Segal DM. Specific targeting of cytotoxicity T cells by anti-T3 linked to anti-target cell antibody. Nature 1985; 316: 354-356.
7. Canevari S, Stoter G, Arienti F, Bolis G, Colnaghi MI, Di Re EM, Eggermont AMM, Goey SH, Gratama JW, Lamers CHJ, Nooy MA, Parmiani G, Raspagliesi F, Ravagnani F, Scarfone G, Trimbos JP, Warnaar SO, Bolhuis RLH. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T-lymphocytes retargeted by a bispecific monoclonal antibody. J Natl Cancer Inst 1995; 87: 1463-1469.
8. Becker W, Schomann F, Fischbach W, Borner W, Gruner KR. Comparison of 99mTc-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988; 9: 435-447.
9. 111In-oxine labelled white cell scans in the assessment of inflammatory bowel disease. Eur J Nucl Med 1993; 20: 195-200.
10. Read EJ, Keenan AM, Carter CS, Yolles PS, Davey RJ. In vivo traffic of indium-111-oxine labelled human lymphocytes collected by automated apheresis. J Nucl Med 1990; 31: 999-1006.
11. Uchida T, Nemoto T, Yui T, Matsuda S, Kariyone S. Use of technetium-99m as a radioactive label to study migratory patterns of leukocytes. J Nucl Med 1979; 20: 1197-1200.
12. Strauss Lg, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 42: 623-648.
13. 18F2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19: 1154-1161.
14. Osman S, Danpure HJ. Fluorine-18-2-fluoro-2-deoxy-D-glucose (18-FFDG) labelling of human granulocytes to study inflammation of positron-emission tomography (PET). Eur J Nucl Med 1989; 8: 577-581.
15. Lanzavecchia A, Scheidegger D. The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur J Immunol 1987; 17: 105-111.
16. Mezzanzanica D, Canevari S, Menard S, Pupa SM, Tagliabue E, Lanzavecchia A, Colnaghi MI. Human ovarian carcinoma lysis by cytotoxic T cells targetted by bispecific monoclonal antobodies: analysis of the antibody components. Int J Cancer 1988; 41: 609-615.
17. Miotti S, Mantovani LT, Pupa SM, Bellosta P, Colnaghi MI. Characterization of two anti-idiotypic monoclonal antibodies raised against the anti-tumor monoclonal antibody MOv18. J Immunol Res 1989; 1: 59-65.
18. 18F]Fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
19. 18F]2-fluoro-2-deoxy-D-glucose. Nucl Med Biol 1989; 16: 385-387.
20. 18F]2-deoxy-2-fluoro-D-glucose: a paradigm in the routine synthesis of fluorine-18 radiopharmaceuticals. Nucl Med Biol 1989; 16: 533-551.
21. 99mTc-hexamethyl-propyleneaminoxime for labelling leukocytes imaging inflammation. Lancet 1986; II: 946-949.
22. 99mTc-HMPAO labelled leukocytes. Radiology 1988; 166: 767-772.
23. Reynolds JH, Graham D, Smith FW. Imaging inflammation of Tc-99m HM-PAO labelled leukocytes. Clin Radiol 1990; 42: 193-198.
24. Mortelmans L. Clinical usefulness of Tc-99m HMPAO labelled white blood cell imaging in abscesses. Clin Nucl Med 1989; 14: 127-130.
25. Peters AM. Sepsis. Nucl Med Commun 1988; 9: 719-723.
26. Becker W. Radiolabelled granulocytes in inflammatory bowel disease. Diagnostic possibilites and clinical indications. Nucl Med Commun 1988; 9: 693-696.
27. Mortelmans L, Malbrain S, Stuyck J, De Backker C, Heynen MJ, DeRoo M, Verbruggen A. In vitro and in vivo evaluation of granulocytes labeling with [99mTc]d,l-HMPAO. J Nucl Med 1989; 30: 2022-2028.
28. Amersham International plc. Ceretec package insert.
29. Schmidt KG, Poulsen BS, Rasmussen JW, Johansen J, Ronne M. Tc-99m-HMPAO as a lymphocyte label. Radiolab Cell Blood Elem 1990; 209-218.
30. 99mTc-HMPAO. J Nucl Med 1988; 29: 572-577.
31. Hung JC, Corlija M, Volkert WA, Holmes RA. Kinetic analysis of technetium-99m d,l-HMAPO decomposition in aqueous media. J Nucl Med 1988; 29: 1568-1576.
32. Rannie GH, Thakur ML, Ford WL. An experimental comparison of radioactive labels with potential application to lymphocyte migration studies in patients. Clin Exp Immunol 1977; 29: 509-514.
33. Solanki C, Li DJ, Wong A, Miles KA, Sampson CB. Multidose use of hexametazime for leukocyte labelling: a new approach using tin enhancement. Nucl Med Commun 1993; 14: 1035-1040.
34. Brownell AL, Kano M, McKinstry RC, Moskowitz MA, Rosen BR, Brownell GL. PET and MR studies of experimental focal stroke. J Comput Assist Tomogr 1991; 15: 376-382.
35. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916.
36. 18F2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19: 1154-1161.
37. Melder RJ, Elmaleh D, Brownell AL, Brownell GL, Jain RK. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Methods 1994; 175: 79-87.
38. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. I. Soluble agents. J Nucl Med 1976; 17: 480-487.
39. 111In-oxine labelled leukocyte scintigraphy in the detection and localization of active inflammation and sepsis. Med J Aust 1990; 152: 352-357.
40. Saverymuttu SH, Peters AM, Hodgson HJ, et al. Indium-111 autologous leukocyte scanning; comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J 1982; 285: 255-257.
41. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium-111 granulocytes scanning in the assessment of disease extent and activity in inflammatory bowel disease. Gastroenterology 1986; 90: 1121-1128.
42. Fisher B, Packard BS, Read FJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson SM, Rosenberg SA. Tumor localization of adoptively transferred indium-111 labelled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 1989; 7: 250-261.
43. Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B, Aebersold P, Packard BS, Yu MY, Rosenberg SA. In vivo distribution of adoptively transferred indium-111-labelled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 1989; 81: 1709-1717.